Información del artículo
El Texto completo está disponible en PDF
Referencias bibliográficas
[1.]
World Health Organization Global Commision on Women's Health.
Women's Health: towards a better world, World Health Organization, (1994),
[2.]
Del Amo J., Llacer A..
Tendencias sociodemográficas y principales causas de muerte de las mujeres en los países occidentales.
Salud y Medicina de la Mujer, pp. 19-26
[3.]
Instituto Nacional de Estadistica (INE) Movimiento Natural de la Población Española. 1997. Madrid. INE. 2000.
[4.]
Boletín Epidemiológico Semanal.
Red Nacional de Vigilancia Epidemiológica en España.
Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Situación epidemiológica de las enfermedades vasculares arterioscleróticas: mortalidad y morbilidad, 6,15 (1998), pp. 149-152
[5.]
Aranda P., San Juan P., Pereiro R..
Perfil de riesgo cardiovascular en mujeres pre y postmenopáusicas. Resultados a propósito del Estudio DRECA.
Clin., e Invest. Arteriosclerosis, 6 (1994), pp. 44(A)
[6.]
Lemer D., Kannel W..
Patterns of coronary Heart disease morbity and mortality in the sexes: A 26-year follow-up of the Framinhgam population.
Am. Heart J., III (1986), pp. 383-390
[7.]
Colditz G.A., Willet W.C., Stampler M.J., Rorner B., Speizer F.E., Hennekens C.H..
Menopause and the risk of coronary heart disease in women, N.
Engl. J. Med., 316 (1987), pp. 105-1110
[8.]
Matthews K., Meilahn E., Kuffer L., Kelsey S., Caggiula A., Wing E..
Menopause and risk factors for coronary heart disease.
N. Engl. J. Med., 321 (1989), pp. 641-646
[9.]
Castelo-Branco C., Duran M..
Esteroides sexuales y metabolismo lipídico.
Postmenopausiay enfermedad cardiovascular, pp. 49-73
[10.]
Aranda p., Villar J..
En representación del Grupo Al-Andalus. Estudio Epidemiológico Andaluz sobre Factores de Riesgo Vascular. Estudio Al-Andalus.
Consejería de Salud, Junta de Andalucía, (1993),
[11.]
Kannel W., Hjortland M.C., Mcnamara P.M., Gordon T..
Menopause and risk of cardiovascular diseases: the Framingham Study.
Ann. Intern. Med., 85 (1976), pp. 447-452
[12.]
Aranda P., Aranda F.J., Cabero A., Calvo C., Marin R., Palacios S., Aranda P.J., Gorostidi M., Salazar F.J..
Hipertensión y riesgo cardiovascular en la mujer.
Serie Grupos de Trabajo en Hipertensión, Sociedad Española de Hipertensión, (2000),
[13.]
Staessen J.A., Bulpitt C., Fagard R., Kifnen P., Amery A..
The influence of menopause on Blood Pressure.
J. Hum. Hypertens, 3 (1989), pp. 427-433
[14.]
Aranda P., Aranda F.J..
Hipertensión arterial en la mujer postmenopausica: perfil fisiopatológico y aproximación terapéutica.
Hipertensión en mujeres postmenopáusicas, pp. 83-96
[15.]
Eaker E.D., Chesebro J.H., Sacks F.M., Wenger N.K., Whismant J.P., Winston M..
Cardiovascular disease in women.
Circulation, 881 (1993), pp. 1999-2009
[16.]
Aranda P., Aranda F.J..
Hipertensión arterial en la mujer postmenopáusica: aproximación fisiopatológica y terapéutica.
Iberoamerican J. Hypertens, 2 (1995), pp. 363-369
[17.]
Predel H.G..
Hypertension in women:epidemiological, pathophysiological, clinical and therapeutical considerations.
The Feminine Heart, pp. 31-39
[18.]
Portaluppi F., Pansini F., Manfredini R., Mollica G..
Relative influence of menopausal status, age and body mass index on blood pressure.
Hypertension, 29 (1997), pp. 976-981
[19.]
Verdechia P., Schillaci G., Gatteschi C., cols.
Blunted nocturnal falls in blood pressure in hypertensive women with future cardiovascular morbid events.
Circulation, 88 (1993), pp. 986-992
[20.]
Mendelshon M.E., Karas R.H..
Estrogen and the blood vessel wall.
Curr. Op. Cardiology, 9 (1994), pp. 619-626
[21.]
Schiffrin E., Thibanlt G..
Plasma endothelin in human essential hypertension.
A. J. Hypertens, 4 (1991), pp. 303-308
[22.]
Karas R.H., Patterson B.L., Mendelsohn M.E..
Human vascular smooth muscle cells contain functional estrogen receptors.
Circulation, 89 (1994), pp. 1943-1950
[23.]
Owens J.F., Stoney C.M., Mathews K.A..
Menopausal status influences ambulatory blood pressure levels changes during mental stress.
Circulation, 88 (1993), pp. 986-992
[24.]
Aranda P., Aranda F.J..
Arterial hypertension in the postmenopausal woman.
Cardiovasc. Drugs & Therapy, VII (1995), pp. 306-311
[25.]
Stefanick M.L..
The roles of obesity, regional adiposity and physical activity in coronary heart disease in women.
Cardiovascular Health and Disease in Women, pp. 149-256
[26.]
Kuroski de Bold M.I..
Estrogen, natriuretic peptides and the renin-angiotensin system.
Cardiovas Research, 41 (1999), pp. 524-531
[27.]
Aranda P., Martin R., Aranda F.J., López de Novales E..
Does surgical menopause increase the salt sensitivity in women?.
Am. J. Hypertens, 11 (1998), pp. 80A
[28.]
Vivas F., Martell N., Ramon M.C., Ruiz D., Fernandez C., Luque M..
Relaciones entre masa ósea total y tensiones arteriales en la menopausia: un estudio transversal en 333 mujeres.
Hipertensión, 16 (1999), pp. 11A
[29.]
Sakhee K..
Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism.
J. Clin. Endocrinol. Metab., 61 (1985), pp. 368-371
[30.]
Hanes D., Weir M., Sowers J..
Gender considerations in hypertension pathophysiology and treatment.
Am. J. Med., 101 (1996), pp. 105-115
[31.]
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP).
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATPIII).
JAMA, 285 (2001), pp. 2486-2498
[32.]
Stefanick M.L..
The roles of obesity, regional adiposity and physical activity in coronary heart disease in women.
Cardiovascular Health and Disease in women, pp. 149-156
[33.]
Haynes W.G., Mark A.L..
Pharmacological Treatment of obesity : Learning from the clinical trials on hypertension.
J. Hypertens, 20 (2002), pp. 1731-1735
[34.]
Owens S.F., Matthews K.A., Wing R.R., Keiller L.H..
Physical activity and cardiovascular risk: a cross-sectional study of middle-aged postmenopausal women.
Prev. Med., 19 (1990), pp. 147-157
[35.]
Willett W.C., Green A., Stampler M.J., et al.
Relative and absolute excess risk of coronary heart disease among women who smoke cigarettes.
N. Engl. J. Med., 317 (1987), pp. 1303-1309
[36.]
Moore R.D., Pearson T.A..
Moderate alcohol consumption and coronary artery disease.
Medicine, 65 (1986), pp. 242-246
[37.]
Ministerio de Sanidad y Consumo.
Control de la Colesterolemia en España, 2000, Secretaría Técnica del Ministerio de Sanidad y Consumo, (2000),
[38.]
Hatton D.C., McCarron D.A..
Dietary calcium and blood pressure in experimental models of hypertension. A review.
Hypertension, 23 (1994), pp. 513-532
[39.]
Guidelines Committee.
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.
J. Hypertens, 21 (2003), pp. 1011-1053
[40.]
Aranda P., Lopez de Novales E..
Diuretics and the treatment of systemic hypertension.
Am. J. Cardiol., 65 (1990), pp. 72H-76H
[41.]
Felson D.T., Solutskis D., Anderson J.J., Anthony J.M., Kiel D.P..
Thiazide diuretics and the risk of hip fracture.
JAMA, 265 (1991), pp. 370-373
[42.]
Aranda P., Aranda F.J., Aranda-Granados P.J., Lopez Novales E..
Papel de los bloqueantes de los canales de calcio en la mujer hipertensa postmenopáusica.
Medicine, 8 (2001), pp. 54-56
[43.]
Mendelsoln M.E., Karas R.H..
The protective effects of estrogen on the cardiovascular system.
N. Engl. J. Med., 340 (1999), pp. 1801-1811
[44.]
Mosca L., Collens P., Herrington D., Mendelsohn M.D., Pasternak R.C., Robertson R.M., et al.
Hormone Replacement Therapie and Cardiovascular Disease. A Statement for Health care Professionals from the American Heart Association.
Circulation, 104 (2001), pp. 499-503
[45.]
Scuteri A., Bos A., Brant L., Talbot L., Lakatta E., Fleg J..
Hormone Replacement Therapy and Longitudinal Changes in Blood Pressure in Postmenopausal Women.
Ann. Intern. Med., 135 (2001), pp. 229-238
[46.]
Rajkumar Ch., Kingwell B.A., Cameron J..
Hormonal therapy increases arterial compliance inpostmenopausal women.
J. Am. Coll. Cardiol., 30 (1997), pp. 350-356
[47.]
Lip G.Y.H., Beevers M., Churchill D., Beevers D.G..
Hormone Replacement Therapy and Blood Pressure in Hypertensive Women.
J. Human Hypertens, 8 (1994), pp. 491-494
Extracto de la Ponencia en la V Reunión de la Sociedad Vasca de Hipertensión Arterial & II Jornada Bilbína de Hipertensión Arterial. Palacio Euskalduna. Bilbao. 28 de Noviembre 2003
Copyright © 2004. Academia de Ciencias Médicas de Bilbao